Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy
Evaluating immunogenicity, manufacturing feasibility, and safety of a novel, autologous dendritic cell-based immunotherapy
View Publication